Page last updated: 2024-08-21

bucrylate and Autoimmune Diabetes

bucrylate has been researched along with Autoimmune Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Damagé, C; Gouin, E; Hoeltzel, A; Rivereau, AS; Saï, P	1

Other Studies

1 other study(ies) available for bucrylate and Autoimmune Diabetes

Article	Year
Prophylactic oral administration of metabolically active insulin entrapped in isobutylcyanoacrylate nanocapsules reduces the incidence of diabetes in nonobese diabetic mice. Journal of autoimmunity, 1996, Volume: 9, Issue:6 Topics: Administration, Oral; Adoptive Transfer; Animals; Autoantibodies; Bucrylate; Capsules; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppression Therapy; Insulin; Intestinal Absorption; Islets of Langerhans; Male; Mice; Mice, Inbred NOD; T-Lymphocytes	1996

Article

Year

Prophylactic oral administration of metabolically active insulin entrapped in isobutylcyanoacrylate nanocapsules reduces the incidence of diabetes in nonobese diabetic mice.

Journal of autoimmunity, 1996, Volume: 9, Issue:6

Topics: Administration, Oral; Adoptive Transfer; Animals; Autoantibodies; Bucrylate; Capsules; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppression Therapy; Insulin; Intestinal Absorption; Islets of Langerhans; Male; Mice; Mice, Inbred NOD; T-Lymphocytes

1996